Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference
Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 MELBOURNE, Australia and INDIANAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan […]